CYBERDYNE (7779) AI Stock Analysis

• Market Cap: $37.00B
• Dividend Yield: N/A
• Average Volume (3M): 600.50K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.75
• Revenue Growth: 0.71%
• EPS Growth: 60.93%
• Country: JP
• Employees: 227
• Sector: Healthcare
• Sector Strength: 58
• Industry: Medical - Devices
• EPS (TTM): -0.91
• Shares Outstanding: 137,445,820
• 10 Day Avg. Volume: 662,200
• 30 Day Avg. Volume: 600,500
• PEG Ratio: 5.21
• Price to Book (P/B): 1.45
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -93.52
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $364.52
• Price Target Upside: 111.93% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 52 Neutral
• Price Target: ¥176.00 ▲(2.33%Upside)

CYBERDYNE demonstrates potential with strong revenue growth and financial stability, but faces significant profitability challenges. The technical indicators suggest stable but non-bullish market conditions. Valuation concerns persist due to negative earnings, impacting the overall score.

CYBERDYNE Business Overview & Revenue Model

Company Description

CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.

How the Company Makes Money

CYBERDYNE makes money through the sale and leasing of its robotic products and related services. A significant portion of its revenue is derived from the commercialization of the HAL exoskeleton suit, which is utilized in medical facilities for rehabilitation purposes and by individuals with mobility impairments. The company also earns income through service contracts for maintenance and training associated with its products. Additionally, CYBERDYNE engages in research and development partnerships with universities and other organizations, which can lead to joint ventures and additional revenue streams. The company's business model relies on continuous innovation and expansion into new markets, such as elderly care and industrial labor support, to drive growth.

CYBERDYNE Financial Statement Overview

Summary

CYBERDYNE shows strong revenue growth and a healthy equity ratio, indicating long-term stability. However, persistent profitability issues, such as negative net income and negative cash flows, highlight operational inefficiencies and dependency on external financing.

Income Statement

CYBERDYNE's revenue has shown a positive growth trend with an increase from ¥1,792 million in 2020 to ¥4,384 million in 2025. The gross profit margin remains strong, but the company consistently reports negative net income and EBIT, indicating challenges in controlling operating expenses. Despite EBITDA turning positive in 2025, the negative net profit margin and EBIT margin highlight ongoing profitability issues.

Balance Sheet

CYBERDYNE maintains a healthy equity ratio, with stockholders' equity comprising a significant portion of total assets. The debt-to-equity ratio remains low, indicating limited leverage and financial stability. However, the consistent negative net income affects the return on equity, posing growth challenges.

Cash Flow

The company's operating cash flow has been consistently negative, posing liquidity risks. Despite this, CYBERDYNE has improved its free cash flow position in recent years. The free cash flow to net income ratio remains adverse due to negative earnings, and there is substantial reliance on external financing.

Breakdown
Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
4.38B	4.35B	3.29B	2.15B	1.88B
	Gross Profit
2.37B	2.39B	1.79B	1.46B	1.28B
	EBIT
-1.50B	-1.74B	-1.15B	-868.00M	-700.00M
	EBITDA
33.00M	-2.00M	-616.00M	116.00M	-278.00M
	Net Income Common Stockholders
-577.00M	-1.48B	-298.00M	-492.00M	-59.00M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
6.82B	5.16B	17.31B	20.83B	25.71B
	Total Assets
48.55B	50.00B	50.19B	49.46B	48.12B
	Total Debt
434.00M	632.00M	669.00M	575.00M	421.00M
	Net Debt
-6.39B	-4.52B	-7.13B	-5.10B	-6.28B
	Total Liabilities
8.95B	9.52B	8.20B	6.00B	4.33B
	Stockholders Equity
39.58B	40.75B	42.10B	43.42B	43.78B
Cash Flow		Free Cash Flow
-726.00M	-1.07B	-652.00M	-2.34B	-1.85B
	Operating Cash Flow
-430.00M	-850.00M	-143.00M	-564.00M	-775.00M
	Investing Cash Flow
2.33B	-2.08B	2.17B	-1.79B	-2.79B
	Financing Cash Flow
-216.00M	160.00M	14.00M	1.25B	617.00M

CYBERDYNE Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 172.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7779, the sentiment is Negative. The current price of 172 is below the 20-day moving average (MA) of 174.85, above the 50-day MA of 171.32, and below the 200-day MA of 182.27, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 45.66 is Neutral, neither overbought nor oversold. The STOCH value of 8.77 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7779.

CYBERDYNE Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6823	78 Outperform	¥30.15B	10.42		3.02%	8.36%	7.74%
6678	74 Outperform	¥15.77B	12.79		3.67%	5.92%	8.59%
4549	66 Neutral	¥69.14B	33.26		2.50%	1.22%	-8.83%
7600	55 Neutral	¥14.83B	10.23		2.74%	8.35%	-136.31%
Sector *	54 Neutral	$5.41B	3.27	-45.10%	3.29%	16.81%	0.02%
7779	52 Neutral	$37.00B	―	-1.44%	―	0.71%	60.93%
DMTRF		$122.45M	―	-184.59%	―	―	―

CYBERDYNE Corporate Events

CYBERDYNE Inc. Reports Fiscal Year 2025 Financial Results

CYBERDYNE Inc. reported financial results for the fiscal year ending March 31, 2025, highlighting a slight increase in revenue due to product rentals and medical services, despite a decrease in gross profit. The company recorded financial income from investment securities but also faced extraordinary losses due to valuation losses on shares of subsidiaries and affiliates. Operating losses decreased significantly, and R&D expenses rose due to new product development, impacting the overall financial performance.

The most recent analyst rating on (JP:7779) stock is a Buy with a Yen365.00 price target. To see the full list of analyst forecasts on CYBERDYNE stock, see the JP:7779 Stock Forecast page.

CYBERDYNE Reports Improved Losses Amid Revenue Growth

CYBERDYNE Inc. reported a slight increase in revenue for the fiscal year ending March 31, 2025, with a 0.7% rise to 4,384 million yen. Despite this, the company experienced a loss before tax of 879 million yen, which is an improvement from the previous year’s loss of 1,141 million yen. The company has not announced forecasts for the next fiscal year due to uncertainties in its innovative market. The financial results indicate a challenging environment, but the reduction in losses suggests some operational improvements.

The most recent analyst rating on (JP:7779) stock is a Buy with a Yen365.00 price target. To see the full list of analyst forecasts on CYBERDYNE stock, see the JP:7779 Stock Forecast page.